| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:36804361 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:38971454 |
| GO:0006007 | Glucose catabolic process | Decreases phenotype | PMID:26616219 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:38971454 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:38971454 |
| GO:0006641 | Triglyceride metabolic process | Increases phenotype | PMID:38971454 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:28428138 |
| GO:0008194 | Udp-glycosyltransferase activity | Increases phenotype | PMID:40023229 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:36804361 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:23626729; PMID:33398415; PMID:38734220; PMID:39909212 |
| GO:0009410 | Response to xenobiotic stimulus | Increases phenotype | PMID:26616219 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:27413119 |
| GO:0018411 | Protein glucuronidation | Increases phenotype | PMID:36549901 |
| GO:0035358 | Regulation of peroxisome proliferator activated receptor signaling pathway | Affects phenotype | PMID:27413110 |
| GO:0042168 | Heme metabolic process | Increases phenotype | PMID:39069214 |
| GO:0042178 | Xenobiotic catabolic process | Increases phenotype | PMID:9929512 |
| GO:0045795 | Positive regulation of cell volume | Increases phenotype | PMID:38734220 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:23626729 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:26616219; PMID:29548889 |
| GO:0060013 | Righting reflex | Decreases phenotype | PMID:16819505 |
| GO:0090357 | Regulation of tryptophan metabolic process | Decreases phenotype | PMID:39069214 |
| GO:0090592 | Dna synthesis involved in dna replication | Increases phenotype | PMID:29548889 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:38971454 |
| GO:1901113 | Erythromycin metabolic process | Increases phenotype | PMID:16673044 |
| GO:2000614 | Positive regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:40023229 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.